Kidney Benefits Associated With Current Pharmacotherapies in Patients With CKD and Diabetes

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Kidney Benefits Associated With Current Pharmacotherapies in Patients With CKD and Diabetes

By KDIGO FEATURING Peter Rossing

129 views

January 24, 2022

Original Recording Date: 4/17/2021

0 Comments

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Prima…

Feat. D. G. Karalis, M. Myerson

What Does Elevated Troponin Mean in COVID-19?

47:11

Houston Methodist

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

36:53

University of Colorado Department of Medicine

ADPKD: Breakthroughs and Updates

Feat. M. Chondol

23:35

Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch

20:15

Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21

University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

21:33

AdventHealth

FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…

Feat. R. Pratley

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

16:08

Omnipod®

Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)

Feat. V. Shah

26:49

Diana Isaacs

Tirzepatide Updates

33:23

Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran

26:32

Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen

21:19

Patricia Kao

Login

Login

Join VuMedi

Kidney Benefits Associated With Current Pharmacotherapies in Patients With CKD and Diabetes

Related Content